Decheng Capital Leads $45M Series C Round In Chinese Biopharmaceutical Firm KeChow Pharma December 13, 2019

Shanghai KeChow Pharma, a Chinese biopharmaceutical company focused on novel drug discover, has raised US$45million in a series C round of financing led by Decheng Capital. Qiming Venture Partners, Sherpa Capital and existing investor Grains Valley Venture Capital also participated in this round. KeChow Pharma was founded by Dr. Tian Hongqi, Lilly Asia Ventures and […]

Decheng Capital Leads $45M Series C Round In Chinese Biopharmaceutical Firm KeChow Pharma comes originally from China Money Network. All Rights Reserved.